NASDAQ · PIIIHealthcareHealth Services

P3 Health Partners Inc. Common Stock (PIII)

$3.82−6.83%
Close Nov 5, 2026 · split-adjusted
Nov 2, 2026$3.98▼ 55.04% in range
Nov 3, 2025Low $1.52 · High $16.47Nov 2, 2026
What changed · written from our data
As of Nov 5, 2026

P3 Health Partners closed at $3.82 on Nov 5, down 6.83%, 76.8% below its 52-week closing high. Volume of 6.5K shares was 0.38× its 20-day average (below normal).

Split-adjusted performance: -32.1% over one month, +6.7% over six months, -54.8% over one year.

In the quarter ended Jun 30, 2026, revenue was $386.38M, up 8.6% from a year earlier, with a net margin of -0.6%.

Short interest was 11.3K shares at the Oct 15 settlement, down 17.0% from the prior report (0.8% of float, 1.0 days to cover).

Market cap$14.9M3.9M shares
Revenue · quarter$386.4M+8.6% YoY
Diluted EPS$-0.63—
P/E · TTM—P/S 0.0×
Net margin-0.6%Gross 22.3%
Dividend yieldNone
52-week range1.52 – 16.47−76.8% from high
Volume6.5K0.38× 20-day avg
Volatility · 60d68.4%Annualised
Short % of float0.8%1.0 days to cover
Net cash-$99.0MCash $21.3M
Next earnings—Not scheduled
Split-adjusted performance
1W −9.0%1M −32.1%3M −67.0%6M +6.7%YTD +9.5%1Y −54.8%3Y −94.7%5Y —

Earnings reactions

History →

No reported quarters with price history yet.

Rank within Health Services

Percentile among 20 companies (100 = best)

6-month momentum42
Revenue growth59
Net margin22
Value (low P/E)—
Size16

Industry medians: 6-month return +11.1%, revenue growth +7.2%, net margin 3.0%, P/E 72.1×.

Short interest

Details →
Shares short11.3K−17.0% vs prior
Days to cover1.0Settled Oct 15
% of float0.8%
Short vol. 10d36.1%of daily volume

Closest peers by size in Health Services

CompanyPriceToday6MRev. growthNet marginP/EMkt cap
PIIIP3 Health Partners$3.82−6.83%+6.7%+8.6%−0.6%—$14.9M
DCGODocGo$0.2436−6.52%−61.6%−8.7%−21.5%—$24.1MCompare
CCELCryo-Cell International$4.95−2.37%+38.3%0.0%16.2%—$39.9MCompare
EUDAEUDA Health Holdings Limited$14.82−7.38%+10.3%———$44.4MCompare
MGRXMangoceuticals$0.1918−7.39%−43.6%−37.9%−5447.9%—$4.3MCompare
PARKPark Dental Partners$20.14−5.65%+19.3%—2.0%—$95.8MCompare
BRTXBioRestorative Therapies, Inc. Common Stock (NV)$1.510.00%−66.4%−7.3%−9298.3%—$2.1MCompare
ATPCAgape ATP$1.29−13.42%−51.5%−93.4%1117.4%—$1.3MCompare
VMDViemed Healthcare$9.01−10.88%−2.2%+23.9%3.5%23.7$343.2MCompare

News about P3 Health Partners

All news →

No recent articles focused on P3 Health Partners.

Quick answers

What does P3 Health Partners do?
P3 Health Partners Inc is a patient-centered and physician-led population health management company. P3's model aggregates and supports the community's existing healthcare resources to build a network of community providers working together to deliver coordinated and integrated care to patients with a shared commitment to improving patient outcomes, lowering cost, and delivering experience for all.
What is PIII's market cap?
$14.94M, based on the Nov 5 close of $3.82.
Does P3 Health Partners pay a dividend?
No regular cash dividend has been paid in the last year.
How much of PIII is sold short?
11.3K shares, 0.8% of float, as of Oct 15, 2026.
What sector is PIII in?
Healthcare, in the Health Services industry.

About P3 Health Partners

P3 Health Partners Inc is a patient-centered and physician-led population health management company. P3's model aggregates and supports the community's existing healthcare resources to build a network of community providers working together to deliver coordinated and integrated care to patients with a shared commitment to improving patient outcomes, lowering cost, and delivering experience for all. It includes utilization management, care management, disease education, and maintenance of a quality improvement and quality management program for members assigned to the Company. The Company is also responsible for the credentialing of its providers, processing and payment of claims, and the establishment of a provider network for certain health plans.

HQ: Chicago, IL320 employeesListed Dec 6, 2021p3hp.org

Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology